当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Journal of Medicinal Chemistry ( IF 6.205 ) Pub Date : 2019-08-05 , DOI: 10.1021/acs.jmedchem.9b00687
Yunhang Guo,Ye Liu,Nan Hu,Desheng Yu,Changyou Zhou,Gongyin Shi,Bo Zhang,Min Wei,Junhua Liu,Lusong Luo,Zhiyu Tang,Huipeng Song,Yin Guo,Xuesong Liu,Dan Su,Shuo Zhang,Xiaomin Song,Xing Zhou,Yuan Hong,Shuaishuai Chen,Zhenzhen Cheng,Steve Young,Qiang Wei,Haisheng Wang,Qiuwen Wang,Lei Lv,Fan Wang,Haipeng Xu,Hanzi Sun,Haimei Xing,Na Li,Wei Zhang,Zhongbo Wang,Guodong Liu,Zhijian Sun,Dongping Zhou,Wei Li,Libin Liu,Lai Wang,Zhiwei Wang

Aberrant activation of Bruton's tyrosine kinase (BTK) plays an important role in pathogenesis of B-cell lymphomas, suggesting that inhibition of BTK is useful in the treatment of hematological malignancies. The discovery of a more selective on-target covalent BTK inhibitor is of high value. Herein, we disclose the discovery and preclinical characterization of a potent, selective, and irreversible BTK inhibitor as our clinical candidate by using in vitro potency, selectivity, pharmacokinetics (PK), and in vivo pharmacodynamic for prioritizing compounds. Compound BGB-3111 (31a, Zanubrutinib) demonstrates (i) potent activity against BTK and excellent selectivity over other TEC, EGFR and Src family kinases, (ii) desirable ADME, excellent in vivo pharmacodynamic in mice and efficacy in OCI-LY10 xenograft models.
更新日期:2019-08-05

 

全部期刊列表>>
材料学研究精选
胸腔和胸部成像专题
自然科研论文编辑服务
ACS ES&T Engineering
ACS ES&T Water
屿渡论文,编辑服务
杨超勇
周一歌
华东师范大学
南京工业大学
清华大学
中科大
唐勇
跟Nature、Science文章学绘图
隐藏1h前已浏览文章
中洪博元
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
x-mol收录
福州大学
南京大学
王杰
南科大
左智伟
湖南大学
清华大学
王小野
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug